Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 admin Website Related Posts Offer Booklet – Non-Renounceable Entitlement Offer June 6, 2025 Trump Admin Strips “Safety” from AI Oversight Institute in Move to Rebrand June 6, 2025 In-fill RC Drilling at Kamperman Confirms High-Grade Gold June 6, 2025